Evidence map›Paper›PMID 41545818›Full record

ArticleBMC nephrology2026

Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.

Jiebo Huang, Xiaofan Cai, Xingmei Yao, Jingying Shen, Huijuan Wu, Ji Fang, Bingbing Zhu, Hao Wang

Abstract read
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiebo Huang *Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Xiaofan Cai *Department of Nephrology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xingmei YaoDepartment of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Jingying ShenDepartment of Pathology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Huijuan WuDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Ji FangDepartment of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Bingbing ZhuDepartment of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Hao WangDepartment of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. xiaofanavan@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic nephropathy (DN) is a microvascular complication of diabetes and a major cause of chronic renal failure in adults. DN is characterized by the infiltration of inflammatory cells in the renal tubular interstitium, resulting in severe interstitial fibrosis, ultimately leading to end-stage renal disease. However, the exact timing at which different phenotypes of inflammatory cells contribute to interstitial fibrosis in DN remains unclear.

methodsWe collected 45 renal tissues diagnosed with DN through renal biopsy between January 2014 and April 2019 from the Pathology Department of Putuo Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine and the Pathology Department of Shanghai Medical College Fudan University. Immunohistochemistry staining was performed on paraffin-embedded sections to analyze the expression patterns of M1 and M2 macrophages and regulatory T lymphocytes. The severity of renal function impairment was categorized into three groups: CKD stage 1 (16 cases), CKD stage 2 (13 cases), and CKD stages 3–5 (16 cases). The degree of tubulointerstitial fibrosis was divided into three groups: mild fibrosis (16 cases), moderate fibrosis (18 cases), and severe fibrosis (11 cases).

resultsOur findings revealed significant differences in the levels of inflammatory cell infiltration CD68, CD163, CD3, and CD4, as well as in the M1/M2 ratio among the different groups of tubulointerstitial fibrosis. While the severity of interstitial fibrosis did not impact urinary protein excretion, it demonstrated statistically significant differences in renal function decline. When the samples were categorized based on the degree of renal dysfunction, there were significant differences in the levels of CD68, CD163, CD3, CD4, and Foxp3 among the three groups. The infiltration levels of macrophages and lymphocytes increased significantly with renal function decline, with M2-type macrophages being the predominant subtype. The infiltration level of inflammatory cells was associated with renal function decline but not with the ratio of proteinuria to interstitial fibrosis. Macrophage and lymphocyte infiltration levels were consistent, while regulatory T lymphocytes showed a closer association with M1-type macrophages. The rate of interstitial fibrosis was correlated with renal function indicators and macrophage infiltration, with a positive correlation observed with M2-type macrophages. DISCUSSION: Our study demonstrated an association between regulatory T lymphocytes and M1-type macrophages, which may contribute to early lesions of DN. However, their impact was limited. In the late stage of DN, M2-type macrophages significantly increased, inhibiting the immune response but also producing and releasing numerous pro-fibrotic factors, ultimately exacerbating fibrosis and worsening renal function. The phenotypes of macrophages determined the development and prognosis of DN. Therefore, regulating macrophage polarization and subtype transformation represented a promising target for DN treatment.

Indexed as

Diabetic NephropathiesKidneyMacrophagesT-Lymphocytes, RegulatoryAdultAgedAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD3 ComplexCD4 AntigensCD68 MoleculeFemaleFibrosisHumansMaleAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD3 ComplexCD4 AntigensCD68 MoleculeReceptors, Cell SurfaceDiabetic nephropathyM1-type macrophagesM2-type macrophagesRegulatory T lymphocytesRenal fibrosis

Identifiers

PMID41545818
PMCPMC12896357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.